Twist Bioscience Corporation (NASDAQ: TWST) established initial surge of 1.19% at $150.81, as the Stock market unbolted on February 19, 2021. During the day, the stock rose to $153.47 and sunk to $146.79 before settling in for the price of $149.04 at the close. Taking a more long-term approach, TWST posted a 52-week range of $18.52-$214.07.
Nevertheless, stock’s Earnings Per Share (EPS) this year is 8.90%. This publicly-traded company’s shares outstanding now amounts to $46.00 million, simultaneously with a float of $45.39 million. The organization now has a market capitalization sitting at $7.25 billion. At the time of writing, stock’s 50-day Moving Average stood at $163.38, while the 200-day Moving Average is $91.28.
It is quite fundamental to gauge the extent of the productivity of the business which is accounted for 525 workers. It has generated 171,619 per worker during the last fiscal year. Meanwhile, its income per employee was -266,535. The stock had 4.68 Receivables turnover and 0.31 Total Asset turnover. For the Profitability, stocks gross margin was +31.85, operating margin was -130.50 and Pretax Margin of -154.88.
Twist Bioscience Corporation (TWST) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Twist Bioscience Corporation industry. Twist Bioscience Corporation’s current insider ownership accounts for 2.30%, in contrast to 91.40% institutional ownership. According to the most recent insider trade that took place on Feb 12, this organization’s President & CEO sold 2,000 shares at the rate of 167.64, making the entire transaction reach 335,278 in total value, affecting insider ownership by 318,188. Preceding that transaction, on Feb 09, Company’s President & CEO sold 75,000 for 176.53, making the whole transaction’s value amount to 13,239,753. This particular insider is now the holder of 0 in total.
Twist Bioscience Corporation (TWST) Earnings and Revenue Records
Going through the last 3-months fiscal report unveiled on the 12/30/2020, it has been observed that the corporation posted -$0.72 earnings per share (EPS) during the time that was better the consensus figure (set at -$0.74) by $0.02. This company achieved a net margin of -155.31 while generating a return on equity of -57.31. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.78 per share during the current fiscal year.
Twist Bioscience Corporation’s EPS increase for this current 12-month fiscal period is 8.90% and is forecasted to reach -2.86 in the upcoming year.
Twist Bioscience Corporation (NASDAQ: TWST) Trading Performance Indicators
Let’s observe the current performance indicators for Twist Bioscience Corporation (TWST). It’s Quick Ratio in the last reported quarter now stands at 16.70. The Stock has managed to achieve an average true range (ATR) of 15.72. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 71.72.
In the same vein, TWST’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -2.79, a figure that is expected to reach -0.77 in the next quarter, and analysts are predicting that it will be -2.86 at the market close of one year from today.
Technical Analysis of Twist Bioscience Corporation (TWST)
Now, what If we examine the latest scores posted by [Twist Bioscience Corporation, TWST]. During the last 5-days, its volume was better the volume of 0.88 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 16.96% While, its Average True Range was 14.50.
Raw Stochastic average of Twist Bioscience Corporation (TWST) in the period of the previous 100 days is set at 55.80%, which indicates a major rise in contrast to 12.81% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 129.53% that was higher than 95.52% volatility it exhibited in the past 100-days period.